Type 2 Diabetes - Pipeline Review, H2 2012 New Report
Type 2 Diabetes - Pipeline Review, H2 2012, provides an overview of the Type 2 Diabetes therapeutic pipeline. This report provides information on the therapeutic development for Type 2 Diabetes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Type 2 Diabetes. 'Type 2 Diabetes - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC...
View full press release